Posttransplant diabetes mellitus in kidney transplant recipients under tacrolimus immunosuppression.
Khoury
N
N
Renal Transplant Unit/Departments of Nephrology and Urology, H opital de Bicêtre, Universite, Paris-Sud, France.
Kriaa
F
F
Hiesse
C
C
Von Ey
F
F
Durbach
A
A
Ammor
M
M
Hafi
A
A
Djeffal
R
R
Boubenider
S
S
Droupy
S
S
Hammoudi
Y
Y
Eschwege
P
P
Benoît
G
G
Charpentier
B
B
D000328:Adult; D001786:Blood Glucose / Q000378:metabolism; D003920:Diabetes Mellitus / Q000453:epidemiology*; D016903:Drug Monitoring; D005260:Female; D006801:Humans; D006943:Hyperglycemia / Q000453:epidemiology; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications; D012086:Reoperation; D012189:Retrospective Studies; D016559:Tacrolimus / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*
D001786:Blood Glucose; D007166:Immunosuppressive Agents; D016559:Tacrolimus